![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-20df0c0ac71b1108bd56c099d1ab3c57e9d3e391e6eabed9a4977ba65bb26cbb.jpg)
Adalimumab for Adult Patients with Crohn’s Disease: A Review of Clinical Effectiveness
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.